Active — Not RecruitingNot Applicable

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

China2,000 participantsStarted 2011-01-01

Plain-language summary

This multi-center retrospective study collected clinical, laboratory, and CT pulmonary angiography parameters with acute pulmonary embolism patients from admission to predict adverse outcomes within 30 days after admission into hospital.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography Exclusion Criteria: * pregnancy * reception of reperfusion treatment before admission * missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

What they're measuring

Adverse outcomes

Timeframe: 30 days

Trial details

NCT IDNCT05481242

SponsorShengjing Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-31

View on ClinicalTrials.gov More Pulmonary Embolism and Thrombosis trials